These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36165188)

  • 21. Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA.
    Hall W; Lynskey M
    Lancet Psychiatry; 2016 Sep; 3(9):900-6. PubMed ID: 27374072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does liberalisation of cannabis policy influence levels of use in adolescents and young adults? A systematic review and meta-analysis.
    Melchior M; Nakamura A; Bolze C; Hausfater F; El Khoury F; Mary-Krause M; Azevedo Da Silva M
    BMJ Open; 2019 Jul; 9(7):e025880. PubMed ID: 31296507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Zealand's 'Cannabis Legalisation and Regulation Bill': an evidence-based assessment and critique of essential regulatory components towards policy outcomes.
    Fischer B; Daldegan-Bueno D
    N Z Med J; 2020 Jul; 133(1519):103-111. PubMed ID: 32777801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of "home" cultivation policies and the case for community-based cannabis supply.
    Belackova V; Roubalova Stefunkova M; van de Ven K
    Int J Drug Policy; 2019 Sep; 71():36-46. PubMed ID: 31200326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When prohibition works: Comparing fireworks and cannabis regulations, markets, and harms.
    Caulkins JP; Reimer KV
    Int J Drug Policy; 2023 Aug; 118():104081. PubMed ID: 37315476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What impact could the legalisation of recreational cannabis have on the health of the UK? Lessons from the rest of the world.
    Roberts E
    Br J Psychiatry; 2024 Apr; 224(4):117-118. PubMed ID: 38268114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Legalisation of non-medical cannabis in Canada: will supply regulations effectively serve public health?
    Fischer B
    Lancet Public Health; 2017 Dec; 2(12):e536-e537. PubMed ID: 29253435
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationships between sales of legal medical cannabis and alcohol in Canada
    Armstrong MJ
    Health Policy; 2023 Feb; 128():28-33. PubMed ID: 36443110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interrupted time series analysis of Canadian legal cannabis sales during the COVID-19 pandemic.
    Armstrong MJ; Cantor N; Smith BT; Jesseman R; Hobin E; Myran DT
    Drug Alcohol Rev; 2022 Jul; 41(5):1131-1135. PubMed ID: 35316855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Looking back from 2020, how cannabis use and related behaviours changed in Canada.
    Rotermann M
    Health Rep; 2021 Apr; 32(4):3-14. PubMed ID: 33881274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does cannabis legalisation change healthcare utilisation? A population-based study using the healthcare cost and utilisation project in Colorado, USA.
    Delling FN; Vittinghoff E; Dewland TA; Pletcher MJ; Olgin JE; Nah G; Aschbacher K; Fang CD; Lee ES; Fan SM; Kazi DS; Marcus GM
    BMJ Open; 2019 May; 9(5):e027432. PubMed ID: 31092662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Where does the high road lead?" Potential implications of cannabis legalization for pediatric injuries in Canada.
    Karbakhsh M; Smith J; Pike I
    Can J Public Health; 2018 Dec; 109(5-6):752-755. PubMed ID: 30264194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis policy in The Netherlands: Rationale and design of an experiment with a controlled legal ('closed') cannabis supply chain.
    Knottnerus JA; Blom T; van Eerden S; Mans JHH; Mheen DV; de Neeling JND; Schelfhout DCL; Seidell JC; van Wijk AH; van Wingerde CGK; Brink WVD
    Health Policy; 2023 Mar; 129():104699. PubMed ID: 36566153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of select cannabis use and supply indicators pre- and post-legalization in Canada.
    Fischer B; Lee A; Robinson T; Hall W
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):77. PubMed ID: 34620191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes.
    Hall W
    Int J Drug Policy; 2017 Apr; 42():57-62. PubMed ID: 27908654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis policies in Canada: How will we know which is best?
    Shanahan M; Cyrenne P
    Int J Drug Policy; 2021 May; 91():102556. PubMed ID: 31563287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis legalisation in Canada: a crucial trial balloon.
    Hill KP; George TP
    Lancet Psychiatry; 2019 Jan; 6(1):5-6. PubMed ID: 30579495
    [No Abstract]   [Full Text] [Related]  

  • 38. Non-medical cannabis in North America: an overview of regulatory approaches.
    Lancione S; Wade K; Windle SB; Filion KB; Thombs BD; Eisenberg MJ
    Public Health; 2020 Jan; 178():7-14. PubMed ID: 31600630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact evaluations of drug decriminalisation and legal regulation on drug use, health and social harms: a systematic review.
    Scheim AI; Maghsoudi N; Marshall Z; Churchill S; Ziegler C; Werb D
    BMJ Open; 2020 Sep; 10(9):e035148. PubMed ID: 32958480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Legalization as more effective control? Parallels between the end of alcohol prohibition (1927) and the legalization of cannabis (2018) in Ontario, Canada.
    Crépault JF; Rehm J; Room R
    Int J Drug Policy; 2021 Nov; 97():103367. PubMed ID: 34311148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.